Simvastatin in Critically Ill Patients with Covid-19
the REMAP-CAP Investigators, Thomas E. Hills, Elizabeth Lorenzi, Lindsay R. Berry, Murali Shyamsundar, Farah Al-Beidh, Djillali Annane, Yaseen Arabi, Diptesh Aryal, Carly Au, Abigail Beane, Zahra Bhimani, Marc Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aidan Burrell, Meredith Buxton, Carolyn S. Calfee, Maurizio Cecconi, Allen C. ChengMatthew E. Cove, Michelle A. Detry, Lise J. Estcourt, Mark Fitzgerald, Ewan C. Goligher, Herman Goossens, Cameron Green, Rashan Haniffa, David A. Harrison, Madiha Hashmi, Alisa M. Higgins, David T. Huang, Nao Ichihara, Deva Jayakumar, Peter S. Kruger, Francois Lamontagne, Lamprini Lampro, Patrick R. Lawler, John C. Marshall, Alexina J. Mason, Anna McGlothlin, Shay McGuinness, Zoe K. McQuilten, Bryan J. McVerry, Paul R. Mouncey, Srinivas Murthy, Matthew D. Neal, Alistair D. Nichol, Cecilia M. O'Kane, Rachael L. Parke, Jane C. Parker, Ebenezer Rabindrarajan, Luis F. Reyes, Kathryn M. Rowan, Hiroki Saito, Marlene Santos, Christina T. Saunders, Christopher W. Seymour, Manu Shankar-Hari, Pratik Sinha, B. Taylor Thompson, Alexis F. Turgeon, Anne M. Turner, Frank Van De Veerdonk, Sebastian Weis, Ian S. Young, Ryan Zarychanski, Roger J. Lewis, Colin J. McArthur, Derek C. Angus, Scott M. Berry, Lennie P.G. Derde, Steve A. Webb, Anthony C. Gordon, Daniel F. McAuley